M. Lai

发表

Using the demoralization scale for the early detection of demoralization in health professionals

李佩怡, Yuh‐Cheng Yang, Pei-Yi Li, 2011 .

Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database.

M. Lai, Chung-Yi Li, C. Hsieh, 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

Validation of the national health insurance research database with ischemic stroke cases in Taiwan

Ching-Lan Cheng, Ching-Lan Cheng, Swu-Jane Lin, 2011, Pharmacoepidemiology and drug safety.

Effectiveness of low-dose ASA in prevention of secondary ischemic stroke, the ASA Study Group in Taiwan.

R. Lin, M. Lai, H. Hu, 1997, Thrombosis research.

Establishing a ‘physician's spiritual well-being scale’ and testing its reliability and validity

M. Lai, D. Bridge, C. Fang, 2010, Journal of Medical Ethics.

The Effects of Ergoloid Mesylates and Ginkgo Biloba on the Pharmacokinetics of Ticlopidine

M. Lai, Jin‐ding Huang, Wen-Jen Lu, 2006, Journal of clinical pharmacology.

M. Lai, Chin-Wei Huang, J. Tsai, 2002, The Kaohsiung journal of medical sciences.

Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa PlA1/A2 polymorphisms and ischemic stroke in young Taiwanese

C. Liou, Ching-Kuan Liu, Hua-Lin Wu, 2004, Journal of the Neurological Sciences.

Palliative Care Consultation to Assist Discussion of Ventilator Withdrawal in a Medical Center in Taiwan

M. Lai, Han-Yu Chang, J. Tsai, 2015 .

Studies on pharmacokinetic mechanism of phenytoin resistance in refractory epilepsy.

M. Lai, Jin‐ding Huang, Yu-En Tien, 2013, Journal of pharmaceutical sciences.

Inhibition of CYP3A4 expression by ketoconazole is mediated by the disruption of pregnane X receptor, steroid receptor coactivator-1, and hepatocyte nuclear factor 4&agr; interaction

Yun-Ping Lim, M. Lai, Jin‐ding Huang, 2009, Pharmacogenetics and genomics.

Erythromycin alters the pharmacokinetics of bromocriptine by inhibition of organic anion transporting polypeptide C–mediated uptake

M. Lai, Jin‐ding Huang, Wen-Jen Lu, 2006, Clinical pharmacology and therapeutics.

Pharmacokinetics of metoprolol enantiomers in Chinese subjects of major CYP2D6 genotypes

M. Lai, Jin‐ding Huang, Ching-Ling cheng, 1999, Clinical pharmacology and therapeutics.

Comparison on Bioequivalence of Four Phenytoin Preparations in Patients with Multiple‐Dose Treatment

M. Lai, J. Tsai, Yea-Huei Kao Yang, 1992, Journal of clinical pharmacology.

Get With The Guidelines-Stroke Performance Indicators: Surveillance of Stroke Care in the Taiwan Stroke Registry: Get With The Guidelines-Stroke in Taiwan

J. Jeng, H. Chiou, C. Bai, 2010, Circulation.

Dual effect of valproic acid on the pharmacokinetics of phenytoin

M. Lai, Jin‐ding Huang, 1993, Biopharmaceutics & drug disposition.

NOVEL MUTATIONS OF CYP 3 A 4 IN CHINESE

M. Lai, Jin‐ding Huang, Min-Shung Lin, 2001 .

Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells.

J. Nezu, I. Tamai, M. Lai, 2006, Journal of biomedical science.

R296C and other CYP2D6 mutations in Chinese.

M. Lai, M. Lai, J. Huang, 1995, Pharmacogenetics.

Novel mutations of CYP3A4 in Chinese.

M. Lai, J. Huang, J. Siest, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes

M. Lai, M. Lai, Chiung-Yao Tseng, 1996, Clinical pharmacology and therapeutics.

Propranolol disposition in Chinese subjects of different CYP2D6 genotypes

M. Lai, M. Lai, Jin‐ding Huang, 1995, Clinical pharmacology and therapeutics.

Effect of single- and multiple-dose carbamazepine on the pharmacokinetics of diphenylhydantoin

M. Lai, T. Lin, J. Huang, 1992, European Journal of Clinical Pharmacology.

Magnetic resonance spectroscopic findings in patients with subcortical ischemic stroke.

M. Lai, Y. Hsu, S. Ma, 1995, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: Polymorphism in RFLP and DNA sequence of CYP2D6

M. Lai, Biing-Hui Liu, M. Lai, 1993, Clinical pharmacology and therapeutics.

4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.

M. Lai, H. Eng, Chih-Jen Chang, 2003, The Journal of laboratory and clinical medicine.

The dilemma of treating vertebrobasilar dolichoectasia

M. Lai, Chih-Hung Chen, Yu-Wei Lin, 2012, Clinics and practice.

Reversible Postvaccination Paraneoplastic Encephalomyelitis in a Patient With Lung Adenocarcinoma

M. Lai, Yi-Jen Wu, Chin-Wei Huang, 2010, The International journal of neuroscience.

Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis.

M. Lai, J. C. Lin, G. Shi, 2001, Atherosclerosis.

IS042 Augmentation of Postnatal Neovascularization by Transplantation of Cord Blood-derived Endothelial Progenitor Cells

How-Ran Guo, Hua-Lin Wu, M. Lai, 2000 .

Midbrain hemorrhage presenting with trochlear nerve palsy.

M. Lai, W. Hwang, T. Tsai, 2000, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip.

K. Peck, M. Lai, Hui-Ling Lee, 2005, Pharmacogenomics.

Ischemic stroke in a young woman with ovarian hyperstimulation syndrome.

M. Lai, W. Hwang, N. Hou, 1998, Journal of the Formosan Medical Association = Taiwan yi zhi.

The Correlation between Uric Acid Levels and Amyotrophic Lateral Sclerosis

M. Lai, Th Lin, Yu-Wei Lin, 2013 .

Apolipoprotein B gene polymorphisms in Taiwanese ischemic stroke patients.

M. Lai, J. Huang, C. -. Chen, 1997, Journal of the Formosan Medical Association = Taiwan yi zhi.